These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8516792)

  • 21. [Transfusion-associated graft-versus-host disease].
    Bojanić I; Cepulić BG
    Lijec Vjesn; 2004; 126(1-2):39-47. PubMed ID: 15526751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?
    Fast LD; Nevola M; Tavares J; Reddy HL; Goodrich RP; Marschner S
    Transfusion; 2013 Feb; 53(2):373-81. PubMed ID: 22612327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PEN110 treatment functionally inactivates the PBMNCs present in RBC units: comparison to the effects of exposure to gamma irradiation.
    Fast LD; DiLeone G; Edson CM; Purmal A
    Transfusion; 2002 Oct; 42(10):1318-25. PubMed ID: 12423516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review of transfusion-associated graft-versus-host disease.
    Kopolovic I; Ostro J; Tsubota H; Lin Y; Cserti-Gazdewich CM; Messner HA; Keir AK; DenHollander N; Dzik WS; Callum J
    Blood; 2015 Jul; 126(3):406-14. PubMed ID: 25931584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Transfusion-associated graft-vs-host disease].
    Lillevang ST; Kristensen T
    Ugeskr Laeger; 1992 Oct; 154(43):2964-8. PubMed ID: 1462384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanism.
    van der Mast BJ; Hornstra N; Ruigrok MB; Claas FH; van Rood JJ; Lagaaij EL
    Lancet; 1994 Mar; 343(8900):753-7. PubMed ID: 7907730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of 66 patients definitive with transfusion-associated graft-versus-host disease and the effect of universal irradiation of blood.
    Uchida S; Tadokoro K; Takahashi M; Yahagi H; Satake M; Juji T
    Transfus Med; 2013 Dec; 23(6):416-22. PubMed ID: 24274074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfusion-associated graft-versus-host disease: report of an occurrence following the administration of irradiated blood.
    Lowenthal RM; Challis DR; Griffiths AE; Chappell RA; Goulder PJ
    Transfusion; 1993 Jun; 33(6):524-9. PubMed ID: 8516797
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Hosseini E; Kianinodeh F; Ghasemzadeh M
    Platelets; 2022 Jul; 33(5):666-678. PubMed ID: 34697994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfusion-associated graft-versus-host disease.
    Dwyre DM; Holland PV
    Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of irradiated blood components: practice parameter.
    Przepiorka D; LeParc GF; Stovall MA; Werch J; Lichtiger B
    Am J Clin Pathol; 1996 Jul; 106(1):6-11. PubMed ID: 8701934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppressive effects of chloroquine: potential effectiveness for treatment of post-transfusion graft-versus-host disease.
    Nishimura M; Hidaka N; Akaza T; Tadokoro K; Juji T
    Transfus Med; 1998 Sep; 8(3):209-14. PubMed ID: 9800293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
    Shivdasani RA; Anderson KC
    Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting.
    Ahya R; Douglas JG; Watson HG
    Heart; 1998 Sep; 80(3):299-300. PubMed ID: 9875094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of transfusion-associated graft-versus-host disease with pathogen-reduced platelets with amotosalen and ultraviolet A light: a review.
    Cid J
    Vox Sang; 2017 Oct; 112(7):607-613. PubMed ID: 28833219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Graft versus host disease with fatal outcome after administration of filtered erythrocyte concentrates].
    Heim MU; Munker R; Sauer H; Wolf-Hornung B; Knabe H; Holler E; Böck M; Mempel W
    Beitr Infusionsther; 1992; 30():178-81. PubMed ID: 1284701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultraviolet irradiation modulates MHC-alloreactive cytotoxic T-cell precursors involved in the onset of graft-versus-host disease.
    van Prooijen HC; Aarts-Riemens MI; Grijzenhout MA; van Weelden H
    Br J Haematol; 1992 May; 81(1):73-6. PubMed ID: 1520628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased bacterial infections after transfusion of leukoreduced non-irradiated blood products in recipients of allogeneic stem cell transplants after reduced-intensity conditioning.
    Jaime-Pérez JC; Villarreal-Villarreal CD; Salazar-Riojas R; Méndez-Ramírez N; Vázquez-Garza E; Gómez-Almaguer D
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):526-30. PubMed ID: 25498924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of non-irradiated blood components in Campath (alemtuzumab)-treated renal transplant patients.
    Hui YM; Regan F; Willecombe M; Taube D
    Transfus Med; 2016 Apr; 26(2):138-46. PubMed ID: 26996635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfusion associated GVHD.
    Sohi I; Jacob S
    Indian J Pediatr; 2005 Jun; 72(6):533-5. PubMed ID: 15985746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.